Clincosm LogoSign in Get a demo

High-grade B-cell Lymphoma

Showing 26 - 30 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Camrelizumab,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 10, 2021

Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial (Telemedicine visit)

Withdrawn
  • Large B-cell Lymphoma
  • +4 more
  • Telemedicine visit
  • (no location specified)
Oct 21, 2020

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma Trial in Tianjin (BZ019)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • BZ019
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 15, 2020

Non Hodgkin Lymphoma, High-grade B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Boston (Cyclophosphamide, Alemtuzumab)

Terminated
  • Non Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 10, 2019

Rituximab-containing Immunochemotherapy for Burkitt's or

Completed
  • Burkitt's Lymphoma
  • High-grade B-cell Lymphoma
  • No intervention (observational study)
  • Incheon, Korea, Republic of
    Gachon University Gil Medical Center
Feb 22, 2017